Serum protein profiling by miniaturized solid‐phase extraction and matrix‐assisted laser desorption/ionization mass spectrometry
- 24 May 2005
- journal article
- research article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 19 (12) , 1578-1586
- https://doi.org/10.1002/rcm.1960
Abstract
Serum profiling by matrix‐assisted laser desorption/ionization mass spectrometry (MALDI‐MS) holds promise as a clinical tool for early diagnosis of cancer and other human diseases. Sample preparation is key to achieving reproducible and well‐resolved signals in MALDI‐MS; a prerequisite for translation of MALDI‐MS based diagnostic methods to clinical applications. We have investigated a number of MALDI matrices and several miniaturized solid‐phase extraction (SPE) methods for serum protein concentration and desalting with the aim of generating reproducible, high‐quality protein profiles by MALDI‐MS. We developed a simple protocol for serum profiling that combines a matrix mixture of 2,5‐dihydroxybenzoic acid and α‐cyano‐4‐hydroxycinnamic acid with miniaturized SPE and MALDI‐MS. Functionalized membrane discs with hydrophobic, ion‐exchange or chelating properties allowed reproducible MALDI mass spectra (m/z 1000–12 000) to be obtained from serum. In a proof‐of‐principle application, SPE with chelating material and MALDI‐MS identified protein peaks in serum that had been previously reported for distinguishing a person diagnosed with breast cancer from a control. These preliminary results indicate that this simple SPE/MALDI‐MS method for serum profiling provides a versatile and scalable platform for clinical proteomics. Copyright © 2005 John Wiley & Sons, Ltd.Keywords
This publication has 29 references indexed in Scilit:
- Industrial‐scale proteomics: From liters of plasma to chemically synthesized proteinsProteomics, 2004
- The Human Plasma ProteomeMolecular & Cellular Proteomics, 2004
- Organic solvent extraction of proteins and peptides from serum as an effective sample preparation for detection and identification of biomarkers by mass spectrometryProteomics, 2004
- Current developments in SELDI affinity technologyMass Spectrometry Reviews, 2003
- Characterization of the Low Molecular Weight Human Serum ProteomeMolecular & Cellular Proteomics, 2003
- The human serum proteome: Display of nearly 3700 chromatographically separated protein spots on two‐dimensional electrophoresis gels and identification of 325 distinct proteinsProteomics, 2003
- Depletion of the highly abundant protein albumin from human plasma using the GradiflowProteomics, 2003
- The Human Plasma ProteomeMolecular & Cellular Proteomics, 2002
- Clinical proteomics: translating benchside promise into bedside realityNature Reviews Drug Discovery, 2002
- Use of proteomic patterns in serum to identify ovarian cancerPublished by Elsevier ,2002